Health Care • Medical Specialities
$1.26 ▼ -0.07
(-5.26%)
MKT CAP: $8.4M • VOL: 2.2K
52W L $1 52W H $2
AMS // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $28.1M | $28.3M | $21.3M |
| YoY Revenue Growth % | -0.9% | +32.9% | — |
| Gross Profit | $5.1M | $9.2M | — |
| Gross Margin % | 18.0% | 32.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$3.6M | -$2.8M | $270.0K |
| Operating Margin % | -12.8% | -9.9% | 1.3% |
| Net Income (GAAP) | -$1.6M | $2.2M | $610.0K |
| EBITDA (Normalized) | $2.5M | $3.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $3.1M | $167.0K | $5.7M |
| Capital Expenditures (CapEx) | $7.6M | $7.9M | — |
| Free Cash Flow (FCF) | -$4.5M | -$7.8M | $5.7M |
| FCF Margin % | -16.2% | -27.4% | 26.8% |
| Return on Invested Capital (ROIC %) | -13.8% | -7.0% | — |
| Cash & Short-Term Equivalents | $3.5M | $11.0M | — |
| Total Debt (Short + Long Term) | $0 | $17.3M | — |
| Total Stockholders' Equity | $24.0M | $25.2M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR AMS.